Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for bleeding prevention in kidney biopsy
NCT06622187Phase 4Enrolling by invitation
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Aug 2024
- Primary completion
- Jun 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hemorrhage comparing Desmopressin with Placebo (2 arms). Primary endpoint: Bleeding events at 48 hours. Started Aug 2024; status: enrolling by invitation.
02
Drugs
desmopressin
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT06622187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06622187.